George R. Uhl

Active 1976–2025

170
Papers
27,807
Citations
108
h-index
170
i10-index

Citations

Citations per year for George R. Uhl1932: 1 citations1977: 14 citations1978: 23 citations1979: 42 citations1980: 64 citations1981: 67 citations1982: 91 citations1983: 76 citations1984: 73 citations1985: 45 citations1986: 45 citations1987: 62 citations1988: 27 citations1989: 56 citations1990: 38 citations1991: 45 citations1992: 79 citations1993: 116 citations1994: 186 citations1995: 191 citations1996: 171 citations1997: 215 citations1998: 266 citations1999: 271 citations2000: 254 citations2001: 275 citations2002: 234 citations2003: 322 citations2004: 273 citations2005: 267 citations2006: 289 citations2007: 301 citations2008: 327 citations2009: 266 citations2010: 243 citations2011: 230 citations2012: 172 citations2013: 182 citations2014: 160 citations2015: 122 citations2016: 132 citations2017: 87 citations2018: 96 citations2019: 364 citations2020: 292 citations2021: 320 citations2022: 216 citations2023: 139 citations2024: 221 citations2025: 98 citations2026: 1 citations1933–1976: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,249 citing papers, 40.9% of this breakdownUnited Kingdom: 504 citing papers, 6.3% of this breakdownGermany: 500 citing papers, 6.3% of this breakdownCanada: 350 citing papers, 4.4% of this breakdownFrance: 313 citing papers, 3.9% of this breakdownItaly: 275 citing papers, 3.5% of this breakdownChina: 250 citing papers, 3.2% of this breakdownJapan: 223 citing papers, 2.8% of this breakdownSpain: 217 citing papers, 2.7% of this breakdownAustralia: 182 citing papers, 2.3% of this breakdownNetherlands: 177 citing papers, 2.2% of this breakdownSweden: 127 citing papers, 1.6% of this breakdown
0%40.9%Other 19.9%

Fields

  • Neuroscience46.3%
  • Medicine28.8%
  • Biochemistry, Genetics and Molecular Biology16.4%
  • Psychology3.8%
  • Agricultural and Biological Sciences1.8%
  • Pharmacology, Toxicology and Pharmaceutics0.5%
  • Other2.4%

Topics

  • Neurotransmitter Receptor Influence on Behavior9.2%
  • Receptor Mechanisms and Signaling8.6%
  • Neuroscience and Neuropharmacology Research8.3%
  • Neuropeptides and Animal Physiology6.4%
  • Cannabis and Cannabinoid Research4%
  • Pain Mechanisms and Treatments2.4%
  • Other61.1%

Coauthors

All papers

Open in search
  1. Multi-ancestry genome-wide association study of major depression aids locus discovery, fine mapping, gene prioritization and causal inference

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kenneth S. Kendler, Roseann E. Peterson, Na Cai, Yu Fang, Srijan Sen, Laura J. Scott, Margit Burmeister, Ruth J. F. Loos, Michael Preuß, Ky’Era V. Actkins, Lea K. Davis, Monica Uddin, Agaz H. Wani, Derek E. Wildman, Allison E. Aiello, Robert J. Ursano, Ronald C. Kessler, Masahiro Kanai, Yukinori Okada, Saori Sakaue, Jill A. Rabinowitz, Brion S. Maher, George R. Uhl, William W. Eaton, Carlos S. Cruz-Fuentes, Gabriela Ariadna Martínez-Levy, Adrián I. Campos, Iona Y. Millwood, Zhengming Chen, Liming Li, Sylvia Wassertheil‐Smoller, Yunxuan Jiang, Chao Tian, Nicholas G. Martin, Brittany L. Mitchell, Enda M. Byrne, Swapnil Awasthi, Jonathan R. I. Coleman, Stephan Ripke, PGC-MDD Working Group, China Kadoorie Biobank Collaborative Group, BioBank Japan Project, Tamar Sofer, Robin Walters, Andrew M. McIntosh, Renato Polimanti, Erin C. Dunn, Murray B. Stein, Joel Gelernter, Cathryn M. Lewis, Karoline Kuchenbaecker - Nature Genetics 2024 cited by 170

  2. The neurobiology of addiction

    Authors: , , - Annals of the New York Academy of Sciences 2019 cited by 238

  3. Discovery of the Presence and Functional Expression of Cannabinoid CB2 Receptors in Brain

    Authors: , , , , , , , , , , , , , , , , , - Annals of the New York Academy of Sciences 2006 cited by 540

  4. Species differences in cannabinoid receptor 2 (CNR2gene): identification of novel human and rodent CB2 isoforms, differential tissue expression and regulation by cannabinoid receptor ligands

    Authors: , , , , , , , , , , - Genes Brain & Behavior 2009 cited by 247

  5. PTPRD: neurobiology, genetics, and initial pharmacology of a pleiotropic contributor to brain phenotypes

    Authors: , - Annals of the New York Academy of Sciences 2019 cited by 92

  6. Cannabinoid CB2 receptors: Immunohistochemical localization in rat brain

    Authors: , , , , , , - Brain Research 2006 cited by 807

  7. Brain-Derived Neurotrophic Factor and Obesity in the WAGR Syndrome

    Authors: , , , , , , , , , , , - New England Journal of Medicine 2008 cited by 354

  8. Brain Neuronal CB2 Cannabinoid Receptors in Drug Abuse and Depression: From Mice to Human Subjects

    Authors: , , , , , , , , , , , , , , , , , , , - PLoS ONE 2008 cited by 259

  9. Active behaviours produced by antidepressants and opioids in the mouse tail suspension test

    Authors: , , , , , - The International Journal of Neuropsychopharmacology 2012 cited by 97

  10. Opiate receptor knockout mice define μ receptor roles in endogenous nociceptive responses and morphine-induced analgesia

    Authors: , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 1997 cited by 528

  11. Spiders are special: fear and disgust evoked by pictures of arthropods

    Authors: , , - Evolution and Human Behavior 2008 cited by 169

  12. VMAT2 knockout mice: Heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity

    Authors: , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 1997 cited by 429

  13. A Human-Specific De Novo Protein-Coding Gene Associated with Human Brain Functions

    Authors: , , , , , , , , , , , , , - PLoS Computational Biology, PLoS Comput. Biol. 2010 cited by 135

  14. Rodent BDNF genes, novel promoters, novel splice variants, and regulation by cocaine

    Authors: , , , , , - Brain Research 2005 cited by 296

  15. Animal models of depression in dopamine, serotonin, and norepinephrine transporter knockout mice: prominent effects of dopamine transporter deletions

    Authors: , , , , , , , - Behavioural Pharmacology 2008 cited by 201

  16. Functional Expression of Brain Neuronal CB2 Cannabinoid Receptors Are Involved in the Effects of Drugs of Abuse and in Depression

    Authors: , , , , , , , , , , , , , , , , , , , , , - Annals of the New York Academy of Sciences 2008 cited by 182

  17. Organic labeling influences food valuation and choice

    Authors: , , , , , - NeuroImage 2010 cited by 134

  18. Impaired spatial working memory and decreased frontal cortex BDNF protein level in dopamine transporter knockout mice

    Authors: , , , , - European Journal of Pharmacology 2009 cited by 109

  19. Communication

    Authors: , - Cambridge University Press eBooks 2011 cited by 83

  20. Implications of genome wide association studies for addiction: Are our a priori assumptions all wrong?

    Authors: , , , - Pharmacology & Therapeutics 2013 cited by 76

  21. Visual pathways in the brain of the jumping spider Marpissa muscosa

    Authors: , , , - The Journal of Comparative Neurology 2020 cited by 39

  22. Comparative neuroanatomy of the central nervous system in web‐building and cursorial hunting spiders

    Authors: , , - The Journal of Comparative Neurology 2023 cited by 37

  23. Cocaine reward models: Conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice

    Authors: , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 1998 cited by 510

  24. Cholecystokinin octapeptide-like immunoreactivity: histochemical localization in rat brain.

    Authors: , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 1979 cited by 453